A systematic review of 95 HNSCC patients presented that 39% of cases with PIK3CA mutations are associated with nearly 5 times increase in the risk of recurrence or death in HPV-positive patients [98]. Here, PIK3CA is linked to head and neck squamous cell carcinoma.